Directori de persones
Carlos Aracil Blanch

Carlos Aracil Blanch

Grau: Doctor/a


claracil.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/A-5962-2010

Grups

Publicacions

  • Romero-Gutiérrez M; Pascual S; Márquez L; Gómez-Rubio M; Miquel M; Alarcón C; Ferrer T; Aracil C; Horta D; Latorre R; González Santiago J; Bernal V; Fernández C; Piqueras B; Gutiérrez ML; Martín A; Morillas J; Morales D; Blanco S; Rendón P; Chico I; Testillano M; Delgado C; Matilla A; Gómez Rodríguez R

    Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case series.

    GASTROENTEROLOGIA Y HEPATOLOGIA 47 683-690. .

    [doi:10.1016/j.gastrohep.2023.08.008]

  • Nicoara-Farcau O; Lozano JJ; Alonso C; Sidorova J; Villanueva C; Albillos A; Genescà J; Llop E; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Tantau M; Thompson M; Perez-Campuzano V; Baiges A; Turon F; Hernandez-Gea V; Abraldes JG; Tapias EA; Torres F; Bosch J; Garcia-Pagan JC

    Metabolomics as a tool to predict the risk of decompensation or liver related death in patients with compensated cirrhosis.

    Hepatology 77 2052-2062. .

    [doi:10.1097/HEP.0000000000000316]

  • Escorsell A; Garcia-Pagán JC; Alvarado-Tapia E; Aracil C; Masnou H; Villanueva C; Bosch J

    Pre-emptive TIPS for the treatment of bleeding from gastric fundal varices: Results of a randomised controlled trial.

    JHEP REPORTS 5 100717-100717. .

    [doi:10.1016/j.jhepr.2023.100717]

  • Bassegoda O; Rivera-Esteban J; Serra I; Morillas R; Broquetas T; Vergara M; Rodriguez A; Aracil C; Virolés S; Carrión JA; Pardo A; Rodríguez-Tajes S; Serra-Burriel M; Pericàs JM; Augustin S; Ginès P; Graupera I

    High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study.

    Hepatology Communications 6 3212-3222. .

    [doi:10.1002/hep4.2056]

  • Sanchez-Aldehuelo, R; Villanueva, C; Genesca, J; Pagan, JCG; Brujats, A; Panero, JLC; Aracil, C; Banares, R; Morillas, RM; Poca, M; Penas, B; Augustin, S; Abraldes, J; Alvarado-Tapias, E; Torres, F; Bosch, J; Albillos, A

    Worsening of low-grade systemic inflammation heralds decompensation in patients with compensated cirrhosis

    JOURNAL OF HEPATOLOGY 77 370-370. .

  • Garcia Garcia de Paredes A; Villanueva C; Blanco C; Genescà J; Manicardi N; Garcia-Pagan JC; Calleja JL; Aracil C; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Royo F; Garcia-Bermejo ML; Falcon-Perez JM; Bañares R; Bosch J; Gracia-Sancho J; Albillos A

    Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis.

    JHEP REPORTS 3 100368-100368. .

    [doi:10.1016/j.jhepr.2021.100368]

  • Villanueva, C; Albillos, A; Genesca, J; Garcia-Pagan, JC; Brujats, A; Calleja, JL; Aracil, C; Bañares R; Morillas, RM; Poca, M; Peñas B; Augustin, S; Abraldes, JG; Alvarado, E; Torres, F; Bosch, J; PreDesCI Study Investigators

    Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.

    JOURNAL OF HEPATOLOGY 75 589-599. .

    [doi:10.1016/j.jhep.2021.04.022]

  • Tapias EA; Ardevol, A; Garcia-Guix, M; Montañés R; Pavel, O; Cuyas, B; Graupera, I; Brujats, A; Vilades, D; Colomo, A; Poca, M; Torras, X; Guarner, C; Concepcion, M; Aracil, C; Torres, F; Villanueva, C

    Short-term hemodynamic effects of ß-blockers influence survival of patients with decompensated cirrhosis.

    JOURNAL OF HEPATOLOGY 73 829-841. .

    [doi:10.1016/j.jhep.2020.03.048]

  • Ardevol A; Alvarado-Tapias E; Garcia-Guix M; Brujats A; Gonzalez L; Hernández-Gea V; Aracil C; Pavel O; Cuyas B; Graupera I; Colomo A; Poca M; Torras X; Concepción M; Villanueva C

    Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with ß-blockers and ligation.

    Digestive And Liver Disease 52 1017-1025. .

    [doi:10.1016/j.dld.2020.06.005]

  • Ballester-Clau R; Torres Vicente G; Cucala Ramos M; Aracil Blanch C; Miñana Calafat JM; Pijoan Comas E; Reñé Espinet JM; Planella de Rubinat M

    Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding.

    Frontiers in Medicine 7 128-128. .

    [doi:10.3389/fmed.2020.00128]

  • Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J

    beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

    Lancet 393 1597-1608. .

    [doi:10.1016/S0140-6736(18)31875-0]

  • Ardevol, A; Ibañez-Sanz G; Profitos, J; Aracil, C; Castellvi, JM; Alvarado, E; Cachero, A; Horta, D; Miñana J; Gomez-Pastrana, B; Pavel, O; Dueñas E; Casas, M; Planella, M; Castellote, J; Villanueva, C

    Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies

    Hepatology 67 1458-1471. .

    [doi:10.1002/hep.29370]

Projectes

  • ESTRATEGIA DE CRIBAJE DE HEPATITIS “D” EN SUBPOBLACIÓN INMIGRANTE CON ELEVADA PREVALENCIA DE HEPATITIS “B” (PROVINCIA LLEIDA)